Archives 2006

CLIENT NEWS
April 16, 2006
Selexis SA Enters Into Cooperative Relationship Agreement with Henogen SA
Henogen to Use Selexis Technology Platform for Mammalian Cell Line Development

April 9 - 12, 2006
The DNA Gateway Team will be attending BIO2006 Annual International Convention
McCormick Place Convention Center, Chicago, IL, USA
CONTACT US to Schedule a Meeting

March 1, 2006
biopharma insight, The BIO Edition

CLIENT NEWS
February 21, 2006
Selexis SA Presented New Data on MARtech™ at the BioProcess International, European Conference and Exhibition
Patented Technology Significantly Improves the Stability of Production Cell Lines

February 20-23, 2006
DNA Gateway President & CEO will be speaking at "BioProcess International European Conference & Exhibition"
Holiday Inn Progue Congress Center, Czech Republic
MORE

February 10, 2006
Stem Cell Coverage - BioWorld Today
Diversified Risk Important To Investors In Stem Cells

February 8, 2006
Sister Company DNA Bridges In the Media - BioWorld Today
International Symposium On Stem Cell Collaboration.
Strong, Scandals Despite Setbacks Stem Cell Work Stays

February 8, 2006
Diverse Stakeholders Address Overcoming Hurdles To Stem Cell Medicine

February 7, 2006
Cori Gorman in the Media - BioWorld Today
ReNeuron's Results Positive As Stem Cell Meeting Starts

February 7, 2006
"
2006 International Symposium on Stem Cell Collaboration:  Laying the Groundwork for the Commercialization of Stem Cell Research"
San Francisco, California
MORE

January 10, 2006
San Francisco Hosts Symposium on Stem Cell Collaboration

January 9 - 12, 2006
JPMorgan H&Q Healthcare Conference.
The DNA Gateway team will be attending the H&Q Conference
San Francisco, CA USA
Schedule a Meeting

 

 

biopharma insight VOL1 Issue 3 Q4 -
The Competitive Intelligence Issue:
Competitive Intelligence: Key Component of Corporate Decision Making
Biotech Alliances IntelligenceThe Recap Portfolio
Life Science Consulting:An Intelligence Source for Biofinance
Competitive Analysis: A Juxtaposition
Competitive Intelligence & Counter-Intelligence

biopharma insight VOL1 Issue 2 Q2 - The Funding Issue:
Angel Investing: The Largest Private Source of
    Capital for Early Stage Entrepreneurs

Canada's Exchanges: An Alternative for Life Science Financing
Mirror, Mirror, What’s Our Valuation?
Ready, AIM, Finance: Why Targeting Alternate
    Sources of Investment Capital Brings Strategic Value
    as Well as Cash to the Business
The Life Science VC Pitch: Making the First
    Impression the BEST!
Grants: A Non-diluting Source of Start-up Money
London’s Alternative Investment Market (AIM)

biopharma insight VOL1 Issue 1 Q1 - The BIO Issue:
Ever Wondered How to Chair a Session at BIO?
Maximizing Your One-on-one Partnering Experience
    at BIO
The Power of One-on-one Partnering at BIO
Marking Pre-meetings Work for Your Company
How a Business Development Firm Can Help You at
   the BIO Conference
BIO on a Budget

 

 

 

 

 

 

 


home | services | clients | our dna | news | contact us

Copyright © DNA Gateway International 2008. All Rights Reserved. Privacy Policy